Don’t miss your chance to join the Advanced Course on non-classical risk factors in Vienna, October 27! This is not your typical course. Limited places available – once we’re full, that’s it. The next opportunity like this may be a long way off. Secure your spot now: eas.to/NCRFATReg
Azin Kheirkhah
@azinkh.bsky.social
👩🏻🔬Researcher @The Institute of Genetic Epidemiology | EAS Young Fellow | 🎙️AtheroTalk-Podcast | Austria | Medical University of Innsbruck @i-med.ac.at |🫀 #cardiosky | #PCSK9 | She/her ORCID: https://orcid.org/0000-0003-1405-9903
🌍 It's FH Awareness Week! Early detection of Familial Hypercholesterolemia can save lives. 🎙️ Check out our special #AtheroTalk episode to learn about this underdiagnosed condition and help spread the word. Spotify: open.spotify.com/episode/5npU... @eassociety.bsky.social #cardiosky
In this episode of AtheroTalk, we explore a new Consensus Statement that proposes a three-stage, holistic framework for understanding and managing metabolic disease. 🎧 eas.to/ATHTalkE17S 🎧 eas.to/ATHTalkE17A 🎧 eas.to/ATHTalkE17Y
In this special live episode, we sat down with two successful grant recipients: Profs Judith Sluimer and Keith Channon. Get a candid look at what it really takes to secure major research funding & practical advice for grant applicants. 🎧 eas.to/ATHTalkE14S 🎧 eas.to/ATHTalkE14A 🎧 eas.to/ATHTalkE14Y
It was very nice recording this podcast and talking about our research at @helsinki.fi and forming the startup company www.moncytehealth.com!
MONCYTE Health
Unique technology and novel data for personalized and optimal treatment of high cholesterol
moncytehealth.com
@spfisterer.bsky.social, was our guest in the latest episode of AtheroTalk. We talk about his academic journey, his move into biotech, and his vision for the future of precision medicine in atherosclerosis. 🎧 eas.to/ATHTalkE16S 🎧 eas.to/ATHTalkE16A 🎧 eas.to/ATHTalkE16Y
The Focused Update recommends risk-based LDL-C lowering, highlights greater benefit in youth, and adopts SCORE2 and SCORE2-OP to estimate both fatal and non-fatal events up to age 89, with risk thresholds roughly doubled to reflect higher non-fatal event rates. eas.to/guidelines-2...
Grateful to @TouchCardio for the kind invitation to be interviewed. Many thanks to @eassociety.bsky.social and the whole Touch Cardio team for the opportunity, it was a real privilege. #CardioSky Link: touchcardio.com/insight/qa-w...
Q&A with Dr Azin Kheirkhah: touchCARDIO Future Leader 2025 – touchCARDIOLOGY
In this Q&A, Dr Azin Kheirkhah shares how her winding academic journey led her to a passion for atherosclerosis, the impact of collaborative mentorship, and her excitement for how big data, multi-omics and machine learning are reshaping cardiovascular risk prediction and disease prevention.
touchcardio.com
It was great to record an #AtheroTalk podcast and talk about our research and establishing the spinout company www.moncytehealth.com! A big thank you to the #AtheroTalk Team, especially Sanne M. and @azinkh.bsky.social for interviewing me and doing the recording. It has been a very nice experience!
🎧 Have you listened to the latest episode of #AtheroTalk yet? It’s out now and definitely worth a listen! @spfisterer.bsky.social @eassociety.bsky.social 🔗 Tune in now👇🏼 Spotify: open.spotify.com/episode/5X2j... #CardioSky #MedSky #academia
We've launched new expert-led Short Track Courses, designed to equip healthcare professionals with focused, up-to-date knowledge in key areas of lipidology and cardiovascular prevention: eas.to/ShortTracks. All courses are free for EAS members, including National Society and complimentary members.
🎧 Have you listened to the latest episode of #AtheroTalk yet? It’s out now and definitely worth a listen! @spfisterer.bsky.social @eassociety.bsky.social 🔗 Tune in now👇🏼 Spotify: open.spotify.com/episode/5X2j... #CardioSky #MedSky #academia
Novel staging system for systemic metabolic disorders! With actionable treatment
The brand-new EAS Consensus is here—offering a game-changing, clinically actionable roadmap to tackle met disorders linked to obesity. Time to move from treating symptoms to a full-body, root-cause approach @eassociety.bsky.social @cibiocm.bsky.social #EASSoMe
🕷️ How could #tick saliva help treat inflammatory diseases? A team from #MedUniVienna reviews new findings on how bioactive molecules in tick saliva modulate the immune system. Their work reveals potential for innovative therapies beyond disease transmission. ⤵
How tick saliva could help treat inflammatory diseases
Read more about the study!
meduniwien.ac.at
Join us in person or virtually for Cardio-Obstetrics Essentials: Team-Based Management of Cardiovascular Disease and Pregnancy 📅 Oct. 17 – 19 📍Washington DC or virtually www.acc.org/Education-an... @accintouch.bsky.social #CardioSky #CardioTwitter #ACC #CardioOB #ACCCVTeam
Join us for AHA CLCD Council #WIC Committee Webinar AI in Action: Enhancing CV Care, Education & Everyday Life 📅 May 28, 6:30PM EST 🔗 heart.zoom.us/webinar/regi... #CardioSky @ahascience.bsky.social @drlaxmimehta.bsky.social @dranulala.bsky.social @garimasharmamd.bsky.social @erinmichos.bsky.social
🎙️New #AtheroTalk Episode – Now Live! We had the pleasure of speaking with Prof. Noam Zelcer during the #EASCongress2025! ‼️Looking for a PhD? His lab is hiring- deadline soon!!! 🎧Listen now: Spotify: open.spotify.com/episode/6fdY... #PhDPosition #SciencePodcast #CardioSky @eassociety.bsky.social
What does EAS Young Fellows Programm mean?? It means SCIENCE, PASSION, FRIENDSHIP & a touch of ART — all in one squad! Loving the energy at #EASCongress2025 #EASYoungFellows #MyEAS2025 #AtheroTalk
At the EAS Congress, we had the opportunity to record a live episode of the 🎙️#AtheroTalk podcast, featuring Professors Judith Sluimer & Keith Channon, who shared invaluable tips and advice on successful grant applications. We also recorded exciting new episodes-stay tuned! @eassociety.bsky.social
🎙️#AtheroTalk episode 12 is out! Prof. Jeffrey Kroon joins us to share insights on thriving in academic science, from grant writing to leading cutting-edge research. @kroonlab.bsky.social @eassociety.bsky.social #CardioSky 🎧Spotify: open.spotify.com/episode/4rEf...
We’re thrilled that #AtheroTalk was mentioned at the #EAS opening ceremony, what an honor! Huge thanks to our incredible team, dedicated listeners, and EAS for the continued support. It’s been an amazing journey so far! @eassociety.bsky.social #CardioSky #sciencepodcast #PhD #postdoc #MedSky
Which session at #EASCongress2025 are you most excited about? 👀 @eassociety.bsky.social I’ve started building my personal agenda and there’s so much to choose from! Drop your must-see picks below — I might add them to my list! 📝👇
How can we turn what we know about familial hypercholesterolaemia into real-world progress? Join the IAS/EAS Joint Session on Tuesday, 06 May to explore the global state of FH and how implementation science can shape better outcomes. 📍 bit.ly/4aIFlcY
📢 Ready to share your #EASCongress2025 experience? Our Social Media Toolkit is here to help you connect, engage, and spread the word. Find everything you need – hashtags, tips, visuals, and more – all in one place. Let’s amplify the conversation together. 👉 eas-congress.com/2025/social-...
🚨 Abstract deadline 🚨 48th European Lipoprotein Club: eas-elc.org 👉 April 24th. If you love metabolism and related disorders this meeting is for you. Speakers: Ana Paula Arruda, Oliver Bruns, Antje Körner, Claudia Monaco, and Keynote Phil Scherer plus 35 talks selected from abstracts! Please repost
‼️To all early-career researchers: The EASCongress is just around the corner. Tune into our latest #AtheroTalk episode to get familiar with leading researchers before you meet them in person. Give it a listen and let us know what you think! open.spotify.com/episode/3oyl... @eassociety.bsky.social
With just a few days left to register for #EASCongress2025, this is your opportunity to be part of vital conversations and gain insights from leading experts in the field of atherosclerosis. Join us for an enriching and thought-provoking experience 👉 bit.ly/3UYJAKF
🎙️New #AtheroTalk episode just released! We’re joined by Prof. Binder, a leading voice in atherosclerosis research. He shares powerful insights, his journey, and what’s next in the field. Tune in now! @eassociety.bsky.social @cjbinder.bsky.social #CardioSky 🎧 Spotify: open.spotify.com/episode/3oyl...
Ron Blankstein (Boston, USA) will explore how AI is transforming atherosclerosis phenotyping and its implications for imaging – a glimpse into the future of cardiovascular care. Start planning your #EASCongress2025 schedule: bit.ly/3PYELy4
#AtheroTalk A new episode of my fav podcast is finally out! @FloPorsch sit down with Mate Kiss, winner of the 2023 @society_eas Young Investigator Award, to discuss his groundbreaking research on macrophages, complement C3, and atherosclerosis #EASSoMe 🎙️ eas-society.org/2025/atherot...
In this #AtheroTalk episode, @j_rvl shares her passion for cardiovascular prevention, familial hypercholesterolemia, and how she balances research with clinical work. Don’t miss this insightful conversation! 🎧 eas.to/ATHTalkE09S #EASSoMe @eassociety.bsky.social
Don't miss Episode 9 of #AtheroTalk with Prof. Jeanine Roeters van Lennep! We talk about her journey in atherosclerosis research, leadership, diversity in science, and the impact of tech and social media in academia. #CardioSky @eassociety.bsky.social 🎧 Spotify: open.spotify.com/episode/0kP5...